58 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
AMPH Amphastar Pharmaceuticals, Inc. $18.33 $847.88M N/A
Article Searches
AmerisourceBergen (ABC) Gains on World Courier Unit Strength http://www.zacks.com/stock/news/292038/amerisourcebergen-abc-gains-on-world-courier-unit-strength?cid=CS-ZC-FT-292038 Feb 09, 2018 - AmerisourceBergen's (ABC) World Courier business gets GDP designation.
Can Pharmacy Services Drive CVS Health's (CVS) Q4 Earnings? http://www.zacks.com/stock/news/290621/can-pharmacy-services-drive-cvs-healths-cvs-q4-earnings?cid=CS-ZC-FT-290621 Jan 30, 2018 - CVS Health's (CVS) Q4 earnings are expected to gain from strength in the Pharmacy Services segment.
What's in Store for Cardinal Health (CAH) in Q2 Earnings? http://www.zacks.com/stock/news/290520/whats-in-store-for-cardinal-health-cah-in-q2-earnings?cid=CS-ZC-FT-290520 Jan 30, 2018 - Pricing pressure in generics portfolio is likely to mar Cardinal Health's (CAH) top line in Q2.
Will Higher System Sales Drive Cerner's (CERN) Q4 Earnings? http://www.zacks.com/stock/news/290374/will-higher-system-sales-drive-cerners-cern-q4-earnings?cid=CS-ZC-FT-290374 Jan 29, 2018 - Cerner (CERN) expects solid Q4 revenues on a surge in bookings. Stiff competition remains a concern.
Can Molecular Diagnostics Arm Up Hologic (HOLX) Q1 Earnings? http://www.zacks.com/stock/news/290442/can-molecular-diagnostics-arm-up-hologic-holx-q1-earnings?cid=CS-ZC-FT-290442 Jan 29, 2018 - Molecular Diagnostics unit's stellar performance in the first quarter of 2018 is likely to drive Hologic (HOLX) in Q1.
AMPH: Needham reits Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20171201072943 Dec 01, 2017 - Needham issues rating change for AMPH
Amphastar Pharmaceuticals (AMPH) Presents At PiperJaffray 29th Annual Healthcare Conference - Slideshow https://seekingalpha.com/article/4128532-amphastar-pharmaceuticals-amph-presents-piperjaffray-29th-annual-healthcare-conference?source=feed_sector_healthcare Nov 29, 2017 - The following slide deck was published by Amphastar in conjunction with this event.
Amphastar Pharmaceuticals' (AMPH) Management on Q3 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4122565-amphastar-pharmaceuticals-amph-management-q3-2017-results-earnings-call-transcript?source=feed_sector_healthcare Nov 08, 2017 - Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2017 Earnings Conference Call November 08, 2017 17:00 P.M. ET Executives Jason B. Shandell - President Bill Peters - CFO, SVP, and Treasurer Analysts E
AMPH: Needham reits Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20170927082647 Sep 27, 2017 - Needham issues rating change for AMPH
Amphastar Pharmaceuticals' (AMPH) Management on Q2 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4097134-amphastar-pharmaceuticals-amph-management-q2-2017-results-earnings-call-transcript?source=feed_all_articles Aug 10, 2017 - Amphastar (NASDAQ:AMPH) Q2 2017 Earnings Conference Call August 9, 2017 5:00 P.M. ET Executives Jason Shandell - President Bill Peters - Chief Financial Officer Analysts David Maris - Wells Fargo Elli

Pages: 123456

<<<Page 5